RVTYRevvity

Health care · Lab Instruments · NYSE

We are a leading provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. 10-K, Item 1

Employees: 11,000
Headquarters: Waltham, MA
CEO: Prahlad R. Singh
Next results: around Jan 12, 2027

Compare with peers → Embed

The numbers RVTY said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.

Of 2 range targets with a reported result: 0 came in above the last range given, 2 within it, 0 below it.

Target	What the company said	Reported	Result
Diluted EPS (company-defined) Fiscal 2026	Given $5.35 to $5.45 release 2026-02-02 Lowered $5.20 to $5.30 release 2026-05-05 Raised $5.30 to $5.40 release 2026-08-04 Raised $5.40 to $5.45 release 2026-11-03	–	No standard number
The company's words Initiates Full Year 2026 Guidance … For the full year 2026, the Company forecasts total revenue of $2.96-$2.99 billion, organic revenue growth of 2-3%, and adjusted earnings per share of $5.35-$5.45. release 2026-02-02 Full Year 2026 Guidance … For the full year 2026, on a pro forma basis, the Company forecasts total revenue of $2.81-$2.84 billion, pro forma organic revenue growth of 3%-4%, and pro forma adjusted earnings per share of $5.20-$5.30. release 2026-05-05 Full Year 2026 Guidance … For the full year 2026, on a pro forma basis, the Company forecasts total revenue of $2.83-$2.86 billion, pro forma organic revenue growth of 4-5%, and pro forma adjusted earnings per share of $5.30-$5.40. release 2026-08-04 For the full year 2026, on a pro forma basis, the Company forecasts total revenue of approximately $2.86 billion, pro forma organic revenue growth of approximately 5%, and pro forma adjusted earnings per share of $5.40-$5.45. release 2026-11-03
Revenue Fiscal 2026	Given $2.96B to $2.99B release 2026-02-02 Lowered $2.81B to $2.84B release 2026-05-05 Raised $2.83B to $2.86B release 2026-08-04 Raised $2.86B release 2026-11-03	–	Not reported yet
The company's words For the full year 2026, the Company forecasts total revenue of $2.96-$2.99 billion, organic revenue growth of 2-3%, and adjusted earnings per share of $5.35-$5.45. release 2026-02-02 Full Year 2026 Guidance … For the full year 2026, on a pro forma basis, the Company forecasts total revenue of $2.81-$2.84 billion, pro forma organic revenue growth of 3%-4%, and pro forma adjusted earnings per share of $5.20-$5.30. release 2026-05-05 Full Year 2026 Guidance … For the full year 2026, on a pro forma basis, the Company forecasts total revenue of $2.83-$2.86 billion, pro forma organic revenue growth of 4-5%, and pro forma adjusted earnings per share of $5.30-$5.40. release 2026-08-04 Full Year 2026 Guidance … For the full year 2026, on a pro forma basis, the Company forecasts total revenue of approximately $2.86 billion, pro forma organic revenue growth of approximately 5%, and pro forma adjusted earnings per share of $5.40-$5.45. release 2026-11-03
Revenue (company-defined) Fiscal 2026	Given $2.81B to $2.84B release 2026-05-05 Raised $2.83B to $2.86B release 2026-08-04	–	No standard number
The company's words For the full year 2026, on a pro forma basis, the Company forecasts total revenue of $2.81-$2.84 billion, pro forma organic revenue growth of 3%-4%, and pro forma adjusted earnings per share of $5.20-$5.30. release 2026-05-05 For the full year 2026, on a pro forma basis, the Company forecasts total revenue of $2.83-$2.86 billion, pro forma organic revenue growth of 4-5%, and pro forma adjusted earnings per share of $5.30-$5.40. release 2026-08-04
Diluted EPS (company-defined) Fiscal 2025 (ended 2025-12-28)	Given $4.90 to $5.00 release 2025-01-31 Kept $4.90 to $5.00 release 2025-04-28 Lowered $4.85 to $4.95 release 2025-07-28 Raised $4.90 to $5.00 release 2025-10-27	–	No standard number
The company's words Initiates Full Year 2025 Guidance … For the full year 2025, the Company forecasts total revenue of $2.80-$2.85 billion and adjusted earnings per share of $4.90-$5.00. release 2025-01-31 Full Year 2025 Guidance … Additionally, the Company is reaffirming its adjusted EPS guidance of $4.90-$5.00. release 2025-04-28 Full Year 2025 Guidance … The Company is also updating its adjusted EPS guidance to a range of $4.85 to $4.95. release 2025-07-28 Full Year 2025 Guidance … The Company is also raising its adjusted EPS guidance to a range of $4.90 to $5.00. release 2025-10-27
Revenue Fiscal 2025 (ended 2025-12-28)	Given $2.80B to $2.85B release 2025-01-31 Raised $2.83B to $2.87B release 2025-04-28 Raised $2.84B to $2.88B release 2025-07-28 Lowered $2.83B to $2.88B release 2025-10-27	$2.86B 10-K filed 2026-02-24	Within the range
The company's words For the full year 2025, the Company forecasts total revenue of $2.80-$2.85 billion and adjusted earnings per share of $4.90-$5.00. release 2025-01-31 For the full year 2025, the Company is raising its revenue guidance to a range of $2.83-$2.87 billion to reflect recent changes in foreign currency exchange rates and is reaffirming its organic growth guidance of 3-5%. release 2025-04-28 For the full year 2025, the Company is raising its full year revenue guidance to $2.84-$2.88 billion to reflect recent changes in foreign currency exchange rates and assumes 2% to 4% organic growth. release 2025-07-28 For the full year 2025, the Company is updating its full year revenue guidance to $2.83-$2.88 billion to reflect recent changes in foreign currency exchange rates and is reaffirming its organic growth guidance of 2% to 4%. release 2025-10-27
Diluted EPS (company-defined) Fiscal 2024 (ended 2024-12-29)	Given $4.55 to $4.75 release 2024-02-01 Kept $4.55 to $4.75 release 2024-04-29 Raised $4.70 to $4.80 release 2024-07-29 Raised $4.83 to $4.87 release 2024-11-04	–	No standard number
The company's words Initiates Full Year 2024 Guidance For the full year 2024, the Company forecasts total revenue of $2.79-$2.85 billion and adjusted earnings per share of $4.55-$4.75. release 2024-02-01 Full Year 2024 Guidance … The Company is also reaffirming its adjusted EPS guidance of $4.55-$4.75 and organic growth guidance of 1-3%. release 2024-04-29 Full Year 2024 Guidance … The Company is also raising its adjusted EPS guidance to a range of $4.70-$4.80. release 2024-07-29 Full Year 2024 Guidance … The Company is also raising its adjusted EPS guidance to a range of $4.83 to $4.87. release 2024-11-04
Revenue Fiscal 2024 (ended 2024-12-29)	Given $2.79B to $2.85B release 2024-02-01 Lowered $2.76B to $2.82B release 2024-04-29 Lowered $2.77B to $2.79B release 2024-07-29 Lowered $2.75B to $2.77B release 2024-11-04	$2.76B 10-K filed 2025-02-25	Within the range
The company's words Initiates Full Year 2024 Guidance For the full year 2024, the Company forecasts total revenue of $2.79-$2.85 billion and adjusted earnings per share of $4.55-$4.75. release 2024-02-01 For the full year 2024, the Company is updating its full year 2024 total revenue guidance to a range of $2.76-$2.82 billion to reflect recent changes in foreign currency exchange rates. release 2024-04-29 For the full year 2024, the Company is updating its full year revenue guidance to $2.77-$2.79 billion to reflect recent changes in foreign currency exchange rates and assumes 2% organic revenue growth. release 2024-07-29 For the full year 2024, the Company is updating its full year revenue guidance to $2.75-$2.77 billion to reflect recent changes in foreign currency exchange rates and assumes 0% to 1% organic growth. release 2024-11-04

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (15 releases since 2024-01-09), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Work on RVTY in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/RVTY/export.csv") into a cell.